Recipharm to construct new Indian fill-finish facility as part of existing relationship with Nichepharm founding family'

The Chinese healthcare market has transformed dramatically in the past few years. This is best seen in the growth of the biosimilars market.

What can we expect in the next few quarters in such a competitive market?

With the demand for safer ways to travel, could we see an increase in Intelligent Payments?